Abbott is a medical - devices company in the healthcare sector trading on NYSE, led by CEO Robert Ford, with a market cap of $195.12B.
Upcoming earnings announcement for Abbott
Past 12 earnings reports for Abbott
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Jan 22, 2026 | Q4 2025 | $1.50Est: $1.50 | 0.0% | $11.5BEst: $11.8B | -2.9% | |
| Oct 15, 2025 | Q3 2025 | $1.30Est: $1.30 | 0.0% | $11.4BEst: $11.4B | -0.3% | |
| Jul 17, 2025 | Q2 2025 | $1.26Est: $1.25 | +0.8% | $11.1BEst: $11.0B | +0.9% | |
| Apr 16, 2025 | Q1 2025 | $1.09Est: $1.07 | +1.9% | $10.4BEst: $10.4B | -0.3% | |
| Jan 22, 2025 | Q4 2024 | $1.34Est: $1.34 | 0.0% | $11.0BEst: $11.0B | -0.5% | |
| Oct 16, 2024 | Q3 2024 | $1.21Est: $1.20 | +0.8% | $10.6BEst: $10.6B | +0.8% | |
| Jul 18, 2024 | Q2 2024 | $1.14Est: $1.10 | +3.6% | $10.4BEst: $10.4B | +0.1% | |
| Apr 17, 2024 | Q1 2024 | $0.98Est: $0.95 | +3.2% | $10.0BEst: $9.9B | +0.9% | |
| Jan 24, 2024 | Q4 2023 | $1.19Est: $1.19 | 0.0% | $10.2BEst: $10.2B | +0.6% | |
| Oct 18, 2023 | Q3 2023 | $1.14Est: $1.04 | +9.6% | $10.1BEst: $9.3B | +8.8% | — |
| Jul 20, 2023 | Q2 2023 | $1.08Est: $1.05 | +2.9% | $10.0BEst: $9.7B | +2.9% | |
| Apr 19, 2023 | Q1 2023 | $1.03Est: $0.99 | +4.0% | $9.7BEst: $9.6B | +1.1% | — |
We use cookies for analytics. See our Privacy and Cookie Policy.